Adil Farooq WaliDr. Adil Farooq Wali, Ph.D., is an accomplished academic and researcher in pharmaceutical sciences, currently serving as an Associate Professor of Pharmaceutical Chemistry at RAK College of Pharmacy, RAK Medical and Health Sciences University, Ras Al Khaimah, United Arab Emirates. In addition to his faculty role, he oversees the Institutional Effectiveness Department, contributing to quality assurance, curriculum development, and educational innovation at the university.Dr. Wali earned his Ph.D. in Pharmaceutical Sciences from the University of Kashmir, India, where he developed a strong foundation in natural product chemistry and pharmacology. His research expertise centers on the isolation and structural elucidation of bioactive compounds from medicinal and marine plants, exploring their pharmacological potential for therapeutic applications. Over the years, he has authored numerous articles in high-impact, peer-reviewed international journals and contributed to globally recognized books and book chapters. His academic excellence has been acknowledged through multiple awards and prestigious fellowships.With a robust research portfolio comprising over 100 publications and an h-index of 20, Dr. Wali has made significant contributions to natural product pharmacology, drug development, and molecular therapeutics. His work strongly aligns with the United Nations Sustainable Development Goals, particularly in promoting health and well-being. Notably, more than 93% of his publications involve international collaborations, and a substantial portion appears in the top 25% of most cited journals, reflecting the global impact of his research.Currently, Dr. Wali’s research interests include the molecular pharmacology of natural products, herbal medicine use among migrant communities, and the role of functional foods and indigenous remedies in improving population health. His work bridges traditional knowledge systems with modern pharmacological science, offering innovative solutions to contemporary healthcare challenges. By integrating evidence-based approaches with holistic strategies, Dr. Wali continues to advance research that addresses global health priorities and fosters sustainable therapeutic practices.Muneeb U. RehmanMuneeb U. Rehman is a Faculty member at the College of Pharmacy, King Saud University, Riyadh, Saudi Arabia. He holds a doctorate in Toxicology (specialization in cancer biology and natural product research) from Jamia Hamdard, New Delhi, India. Dr.Rehman has more than IO years of research and teaching experience in the 1eld of toxicology, biochemistry, cancer biology, natural product research, and pharmacogenomics. He received several national and international fellowships and awards. He has published more than I00 research papers in peer-reviewed, international journals, and has 2 edited books and 26 book chapters to his name. Dr. Rehman is on the editorial boards and is a reviewer of several high-impact, international scientific journals. He is also a life member of various international societies and organizations. Currently, Dr. Rehman is engaged in studying the molecular mechanisms of cancer prevention by natural products and the role of pharmacogenomics and toxicogenomic in evaluating the effectiveness and safety of drugs.Imran Rashid RangrazeDr. Imran Rashid Rangraze, MD, MRCP (UK), FRCP (London, Glasgow, Edinburgh), FACP Professor and Chairperson, Department of Internal Medicine Ras Al Khaimah Medical and Health Sciences University, UAE. Dr. Imran Rashid Rangraze is a senior academic clinician, medical educator, and scientific editor with over 20 years of post-graduate experience in Internal Medicine across tertiary healthcare and university systems in the Middle East, the United Kingdom, and South Asia. He currently serves as Professor and Chairperson of the Department of Internal Medicine at Ras Al Khaimah Medical and Health Sciences University (RAKMHSU), UAE, and is a practicing Physician at RAK Hospital and NMC Royal Hospital. He is an International MRCP (UK) PACES Examiner and a recognized author for the MRCP UK Part 1 and Part 2 examination question banks, contributing to global postgraduate medical education. Dr. Rangraze holds Fellowships from all three Royal Colleges of Physicians in the United Kingdom (London, Glasgow, and Edinburgh) and the American College of Physicians (FACP), reflecting sustained excellence in clinical leadership, education, and scholarship.Dr. Rangraze has authored more than 60 peer-reviewed national and international publications, including original research articles, systematic reviews, and meta-analyses published in high-indexed journals. His scholarly work spans artificial intelligence in healthcare, diabetes and metabolic disorders, cardiovascular medicine, oncology, geriatrics, and precision medicine. In recent years, his research has increasingly focused on AI-enabled diagnostics, machine-learning–driven clinical prediction models, digital health technologies, and the integration of artificial intelligence into real-world clinical decision-making.He serves as an Editorial Board Member for multiple international medical journals and is a reviewer for leading journals, including the British Medical Journal (BMJ), BMC, Journal of Diabetes and Its Complications, F1000Research, and several other indexed journals. He is also a Publons-certified medical journal reviewer, underscoring his commitment to research integrity and high editorial standards.In addition to his research and editorial roles, Dr. Rangraze is deeply involved in medical education innovation, including competency-based curricula, OSCE design, simulation-based assessment, and the incorporation of AI-assisted tools in undergraduate and postgraduate training. As an editor of this volume, he brings a clinician-scientist’s perspective to artificial intelligence, emphasizing ethical implementation, clinical relevance, translational impact, and evidence-based adoption of AI technologies in modern healthcare systems.Sirajunisa TalathSirajunisa Talath, Ph.D., currently holds the position of Professor within the Department of Pharmaceutical Chemistry at RAK College of Pharmacy, part of RAK Medical & Health Sciences University in Ras Al Khaimah. With over two decades of teaching experience, she has contributed extensively to both undergraduate and master's level education.Her research primarily revolves around the synthesis of diverse heterocycles known for their significant biological activities. Additionally, she conducts phytochemical and biological investigations focusing on medicinal plants. A key aspect of her current research involves the development of nanoparticles with biological relevance, particularly in the context of cancer activity.Dr. Talath's research also delves into the study of antimicrobials, antioxidants, and cancer, emphasizing the biological activities of synthesized heterocycles and phytochemical extracts. The outcomes of her studies have been disseminated through publications in reputable high-impact journals. Furthermore, she actively participates in various national and international conferences, where she presents her research findings to contribute to the advancement of pharmaceutical sciences.Sathvik B. SridharDr. Sathvik is currently employed as a Professor of Clinical Pharmacy and Pharmacology at RAK College of Pharmacy (RAKCOP), RAK Medical and Health Sciences University, located in Ras Al Khaimah, United Arab Emirates. Dr. Sathvik has completed his Ph.D. in Clinical Pharmacy and received advanced training in renal clinical pharmacy at Royal Adelaide Hospital and Queen Elizabeth Hospital in Adelaide, South Australia. Dr. Sathvik has been recognized for his exceptional academic achievements in the M. Pharm Clinical Pharmacy Branch. He has been awarded the prestigious Gold Medal for securing the highest marks and has been acknowledged as the best outgoing postgraduate student.With 25 years of experience teaching and practicing clinical pharmacy in India, Malaysia, and the UAE, he brings a wealth of knowledge and expertise to the table. Dr. Sathvik has provided extensive training to students in various areas of pharmacy, including clinical pharmacy, hospital pharmacy, and community pharmacy. Furthermore, Dr. Sathvik has guided numerous MS clinical pharmacy students. Dr. Sathvik has extensive experience as an external examiner and thesis evaluator for Master's and Ph.D. examinations, both nationally and internationally.Over 200 research papers have been published in reputable national and international journals, along with several book chapters, and I have edited four books. Dr. Sathvik's research interests encompass a wide range of topics, including pharmacoepidemiology, Pharmacovigilance, renal, and psychiatry clinical pharmacy. He has been honored with a prestigious teacher award. The award was presented at the international conference organized by the Bangkok Society of Pharmaceutical Education & Research [SPER]. He received training in Pharmacovigilance at the Uppsala Monitoring Centre in Uppsala, Sweden. He has shared more than 75 research papers at numerous national and international conferences and has been honored with multiple awards. In addition, he serves as a reviewer for various national and internal pharmacy practice-related journals. In addition, he has served as an external reviewer for the clinical pharmacy curriculum at numerous national and international universities. Furthermore, he actively serves as a speaker at several clinical pharmacy workshops, symposia, and conferences in the UAE and internationally.
